| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/22/2004 | WO2004007556A1 Expression of hydrophobic proteins |
| 01/22/2004 | WO2004007544A2 Components of the presenilin-complex |
| 01/22/2004 | WO2004007525A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | WO2003054213A3 Non-human primate fc receptors and methods of use |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014174 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same |
| 01/22/2004 | US20040014171 Soluble CTLA4 mutant molecules and uses thereof |
| 01/22/2004 | US20040014134 Two coloured fluorimetric protease assay |
| 01/22/2004 | US20040014128 Comprises nucleotide sequences coding green fluorescent proteins derivative for use as diagnostic tools genetic engineering |
| 01/22/2004 | US20040013681 Stimulant of immunology response |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2491704A1 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | CA2490278A1 Components of the presenilin-complex |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |
| 01/21/2004 | CN1468865A Fusion protein of recombinant SARS virus N protein carboxyl terminal peptide section and GST and its prepn |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680296 Compositions comprising bouganin and a cell binding ligand are particularly useful to kill cells of a target population |
| 01/20/2004 | US6680182 Promoter sequence operably linked to a dna sequence encoding first and second proteins linked by hinge regiion; tetanus toxin c fragments |
| 01/20/2004 | US6680058 Compositions and methods for contraception in or sterilization of mammals |
| 01/15/2004 | WO2004005931A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/15/2004 | WO2004005520A1 Method for preparing fusion polypeptide comprising epidermal growth factor and human serum albumin in plants |
| 01/15/2004 | WO2004005477A2 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/15/2004 | WO2004005473A2 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | WO2004005340A1 Fusion polypeptide comprising epidermal growth factor and human serum albumin |
| 01/15/2004 | WO2004005335A2 Multimerised growth hormone fusion proteins |
| 01/15/2004 | WO2004005322A2 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010124 CD16A binding proteins and use for the treatment of immune disorders |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009558 Ligand binding pocket peptide fragment of the estrogen-related receptor 3 (ERR3) and uses thereof |
| 01/15/2004 | US20040009557 Comprises nucleotide sequences coding non-gum arabic fusion protein for use in food processing and cosmetics |
| 01/15/2004 | US20040009555 Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009166 Single chain antigen-binding polypeptides for polymer conjugation |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491691A1 Protein microarrays on mirrored surfaces for performing proteomic analyses |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1379878A2 Affinity selection-based screening of hydrophobic proteins |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP0942758B1 Compounds with improved inductive effect on cartilage and bones |
| 01/14/2004 | CN1468312A Chimeric gfp-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 01/14/2004 | CN1468123A Method and composition for altering a b cell mediated pathology |
| 01/14/2004 | CN1467224A Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/13/2004 | US6677432 Osteogenic protein-1 mutant having at least one amino acid residue substitution, and having improved in vitro refolding properties in ph range of about 6.0-9.0 |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6676985 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 01/13/2004 | US6676938 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 01/08/2004 | WO2004003207A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies |
| 01/08/2004 | WO2004002424A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |
| 01/08/2004 | WO2003054194A3 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002079448A3 G-protein coupled receptors |
| 01/08/2004 | WO2002068650B1 Modified and stabilized gdf propeptides and uses thereof |
| 01/08/2004 | WO2002050250A3 Signal-1/signal-2 bifunctional peptide inhibitors |
| 01/08/2004 | WO2002038613A3 Modified recombinase |
| 01/08/2004 | US20040006207 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 01/08/2004 | US20040005687 Kinase crystal structures |
| 01/08/2004 | US20040005660 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/08/2004 | US20040005630 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005334 Redirection of cellular immunity by receptor chimeras |
| 01/08/2004 | US20040005333 Recombinant gene fusion encoding a human IgG1 heavy chain constant region and a single-chain variable fragment antibody of 1A4A1 monoclonal antibody is disclosed. The recombinant antibody of the present invention confers human immune |
| 01/08/2004 | CA2491480A1 Humanized anti-lymphotoxin beta receptor antibodies |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490348A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 01/07/2004 | EP1378571A1 5' ESTs for secreted proteins expressed in various tissues |
| 01/07/2004 | EP1378520A1 Cyclic single strand trispecific antibody |
| 01/07/2004 | EP1377314A2 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 01/07/2004 | CN1466682A HCV antigen/antibody combination assay |
| 01/07/2004 | CN1465702A Purifying and use for human vascular endothelial growth factor and granzyme B fusion protein |
| 01/07/2004 | CN1465597A Fusion protein containing soluble tumor necrosis factor II type receptor and interleukin I receptor agonist IL1Ra its preparation process and medicine composition |
| 01/07/2004 | CN1465396A Anti-tumor medicine |
| 01/06/2004 | US6673894 Inhibitor of cell proliferation and methods of use thereof |
| 01/06/2004 | US6673573 Expression of immunoglobulin-cytokine fusion proteins in malignant B cells |
| 01/06/2004 | US6673353 Tuberculosis vaccine |
| 01/06/2004 | US6673348 Heat shock protein-based vaccines and immunotherapies |
| 01/06/2004 | US6673343 Useful for activating their respective receptor and thereby enabling the role of tyrosine kinase receptor in cell growth and/or differentiation to be studied |
| 01/02/2004 | EP1373508A2 Human cytokine receptor |
| 01/02/2004 | EP1373505A2 Tri-hybrid melanoma antigen |